Hepatic CPR null mice could no longer break down cholesterol due to their inability to produce bile acids, and while hepatic lipid levels were significantly increased, circulating levels of cholesterol and triglycerides were severely reduced. Loss of hepatic P450 activity resulted in a five-fold increase in P450 protein, indicating the existence of a negative feedback pathway regulating P450 expression.
Introduction
The hepatic cytochrome P450 (CYP)-dependent monoxygenase system plays a central role in mammalian defence against harmful environmental chemicals (1); it is also a major determinant of the half-life and pharmacological properties of therapeutic drugs and in certain cases, mediates the activation of drugs, toxins and carcinogens to their ultimate toxic species (2, 3) . Several other functions have been ascribed to hepatic P450s, including control of cholesterol and steroid hormone metabolism and bile acid biosynthesis (4) . However, for certain of these pathways, the exact role of P450s in normal homeostasis is unknown.
Over the last four decades, there have been significant advances in understanding the functions, genetics and regulation of these enzymes and more recently their structure (5) . However, a great deal remains to be learned about the expression and regulation of P450s, and their endogenous function(s), particularly in individual tissues. The size and diversity of the P450 multi-gene family results in great difficulties in dissecting out the function(s) of individual enzymes, particularly as many of those involved in foreign compound metabolism exhibit overlapping substrate specificities and may be expressed to a greater or lesser extent in almost every cell and tissue. The contribution that P450s in any particular tissue make to the overall pharmacokinetics of a drug is still, in the majority of cases, unknown. For example, the precise role of P450s in the metabolism of chemotherapaeutic agents, and the generation of side effects, remains unclear, as does the site of metabolism -either systemic (hepatic) or local (tumour site), or both.
To study further the involvement of P450s in the tissue specificity of drug metabolism would require the simultaneous deletion of multiple P450 genes, a process rendered impractical both by the large number of such genes and their location throughout the genome, and our lack of knowledge about the regulation of tissue-specific P450 expression. However, all cytochrome P450s receive by guest on August 17, 2017 http://www.jbc.org/ Downloaded from electrons from a single donor, cytochrome P450 reductase (CPR, NADPH:ferrihemoprotein reductase, EC 1.6.2.4) (6, 7) . Deletion of this protein would therefore inactivate all the P450s located in the endoplasmic reticulum. In view of the known requirement for P450 expression during development, a complete deletion of CPR was anticipated and has recently been shown to be embryonic lethal (8) . We therefore generated mice where CPR could be deleted in the post-natal period in any tissue, using the Cre/loxP system (9) . Below, we describe the generation and characterisation of mice carrying a deletion of hepatic CPR, and thus lacking P450 activity in the liver. Such mice exhibited many intriguing phenotypes, and remarkably they were viable and healthy. In addition, hepatic CPR null mice had a severely compromised ability to metabolise the narcotic drug pentobarbital or the analgesic acetaminophen, demonstrating the predominant role of the hepatic P450 enzymes in the pharmacology and toxicology of these compounds and also demonstrating the power of this model for understanding P450 functions.
Methods

Generation of CPR floxed and knockout mice
A replacement-type targeting vector was constructed from a 12 kb SalI fragment, isolated from a mouse 129/Ola genomic library and containing exons 3-16 of the mouse CPR gene. A cassette, flanked by same-orientation loxP sites and containing a selectable marker (neomycin (neo)), driven by the herpes simplex thymidine kinase (hsv-tk) promotor, was inserted into an XhoI site in intron 4.
A third loxP site was cloned into a BamHI site in intron 15. The correct arrangement of the construct and orientation of all three loxP sites was confirmed by detailed restriction mapping and sequence analysis. The construct was transfected into GK129/1 embryonic (ES) cells by electroporation and the ES cells were subsequently cultured in 96 well plates and G418 selection applied. Eight G418-resistant clones were found to have undergone specific homologous recombination as demonstrated by guest on August 17, 2017 http://www.jbc.org/ Downloaded from by Southern analysis, digesting genomic DNA with KpnI and using a 600 bp PCR fragment generated with primers 1105 (5'-GACCCTGAAGAGTATGACTTG-3') and 1184 (5'-GCTTCCTCTTGCAAAACCACACTGC-3') ( Fig. 1a) , and two of these correctly targeted ES cell clones (CPR lox/+ ) were expanded, injected into C57BL/6 blastocysts and transferred into 2.5 days post-coitum (dpc) recipient pseudopregnant mice. Male chimerae were bred to C57BL/6 mice and heterozygous offspring were screened by Southern analysis to confirm germline transmission of the CPR lox/+ genotype. Five of these ES clones containing the CPR lox locus were transiently transfected with a vector containing the Cre recombinase gene (pMC1Cre). Colonies were obtained without selection and were isolated into a 96 well plate; after 3-4 days the plates were split into two duplicate plates, and after a further 3 -4 days one plate was frozen and the other further split. G418 selection was applied for up to 5 days to one of these plates in order to identify sensitive colonies. DNA was prepared from the duplicate plate after 3-4 days. ES clones (800) were tested by Southern blot analysis as described above. Nine of those clones screened showed excision of the floxed sequence including exons 5 to 15. Two of these ES cell clones (CPR +/-) were expanded and chimaeric mice generated. Male chimerae were bred to C57BL/6 mice and heterozygous offspring were screened by Southern blot analysis to confirm germline transmission. and 24h after treatment, mice were sacrificed (n=4) by a rising concentration of CO 2 and blood and tissues taken for analysis.
Mouse breeding and maintenance
Immunoblotting and biochemical assays
Microsomal fractions were prepared from frozen tissues by differential centrifugation (12) and protein concentration determined as previously described (13) . Western blots were carried out as described previously (14) using 9% SDS/PAGE gels and electroblotted onto nitrocellulose membranes. Polyclonal antisera raised against human CPR (7) and rats P450s (15) Glutathione levels were measured by the method of Sen et al., (16) . Cytochrome P450 reductase activity was determined as previously described (7).
Blood Chemistry
Blood was collected by cardiac puncture into heparinised tubes, and serum prepared by centrifugation. Serum was either analysed immediately or stored at -70 o C for a period not exceeding 4 weeks. Analysis for serum alanine aminotransferase and cholesterol was carried out using commercially available kits (Infinity Reagents, Sigma, Poole, UK) on a Cobas Fara II centrifugal analyser (Roche, UK).
Histopathology
Tissue samples were either fixed in formalin-PBS for 24 h and transferred to 80% ethanol for storage, or snap-frozen embedded in Cryo-M-Bed (Bright Instrument Co., Huntingdon, Cambs., UK)
on cork discs and stored at -70 o C. Formalin-fixed samples were sectioned and stained with haematoxylin and eosin, or processed for immunostaining with a polyclonal antibody against rat CPR or various P450s (15, 17) . Snap-frozen tissue samples were cryo-sectioned and processed for staining with Oil Red O to determine lipid content.
Statistical analysis
Statistical analysis was carried out using the Statview program (v4.5) for Macintosh, Abacus
Concepts, Berkeley, CA. Figure 1a illustrates the targeting strategy adopted in this study. Correct integration of the floxed CPR targeting construct was confirmed by Southern analysis (Fig. 1b) 9.2kb/3.2kb). These latter mice were apparently completely normal, displaying no phenotypic differences from wild-type littermates: their growth and development, blood chemistry, organ size and structure, and fertility were identical (data not shown).
Results
Generation of conditional CPR knockout mice
Generation of hepatic CPR null mice
Specific hepatic deletion of CPR was achieved by crossing CPR lox/lox mice into a line where Cre expression was regulated by the rat albumin promotor (10 was determined by PCR (data not shown). Offspring born from either of these crosses were found in Mendelian proportions as predicted from parental genotype, indicating there was no embryonic lethality from opportunistic expression of the Cre transgene during development.
As the albumin promotor becomes active neonatally, (10) we investigated hepatic CPR levels in adult mice, i.e. from 6-8 weeks of age. CPR lox/-+ Cre ALB and CPR lox/lox + Cre ALB mice displayed no overt phenotypic differences from their wild-type littermates in the postnatal period: mice of these genotypes grew and developed normally. In mice where one CPR allele had been deleted, only half the expression of CPR was found in both males and females ( Hepatic CPR activity in CPR lox/-+ Cre ALB mice was reduced by more than 90% in both males (92.5%) and females (94.5%), and similar reductions were observed in hepatic microsomes from CPR lox/lox + Cre ALB mice of both sexes (Fig. 2b ). The activity of cytochrome b5 reductase, an enzyme which could conceivably transfer electrons from NADH to the P450 system (18), was unchanged (not shown). In liver sections from CPR hepatic null mice stained with a polyclonal antiserum to CPR, only a very few cells contained immunoreactive protein (Fig. 2c) , in contrast to the wild-type mice where CPR immunostaining was extensive across the entire section. 2c ), where the staining was the same in both lines.
Characterisation of hepatic CPR null mice
Hepatic CPR null mice exhibited no overt phenotypic differences to controls. Post-mortem examination revealed that both male and female hepatic CPR nulls displayed hepatomegaly, the liver being almost doubled in size, in relation to body weight (7.5%), compared to wild-type mice (4%). Furthermore, the liver was pale in colour, and the tissue was mottled and friable ( Fig. 3a,b) . Microscopic examination revealed the presence of microvisicular and macrovisicular fatty changes, the former predominating (Fig. 3c , plates i and v vs. iii and vii).
Otherwise, hepatocytes in both the centrizonal and periportal regions appeared normal, with no apparent increase in hepatocyte proliferation or apoptosis.
The livers of mice lacking hepatic CPR were hyperlipidaemic, as evidenced by staining with Oil Red O (Fig. 3c plates ii and vi vs. iv and viii). The increase in hepatic lipid was accompanied by a 90% reduction in the volume of bile acids in the gall bladder in hepatic CPR null mice, compared to wild-type animals (Fig. 3d) , and a 65% reduction in the level of serum cholesterol (Fig. 3e ) and a 50% reduction in serum triglycerides (Fig. 3f) . It is interesting to note that these mice also had a slight but significantly elevated serum ALT, indicating a low level of liver damage or an altered rate of hepatocyte turnover (data not shown).
P450 activity in hepatic CPR null mice
In order to determine the effect of CPR deletion on hepatic P450 monoxygenase activities, we measured the microsomal hydroxylation of testosterone (Fig. 4a) . When expressed as pmol metabolite per nmol P450, a 90% reduction in the formation of 6β-hydroxytestosterone, an activity associated with CYP3A proteins, was measured in both males and females, indicating that a lack of CPR in this tissue resulted in severely compromised P450 function. The 7α-hydroxylation of testosterone, catalysed by P450s of the CYP2A subfamily, was decreased by >99% in both males and females, while 16β-hydroxylation was undetectable in hepatic CPR nulls of both sexes (Fig. 4a) .
In addition to the marked reduction in testosterone metabolism, the O-dealkylation of 7-methoxyresorufin was also almost completely ablated in CPR lox/-+ Cre ALB mice, being reduced by 99.5% in males and 98.5% in females, when expressed nmol metabolite per nmol P450 (not shown).
It is thus clear that hepatic deletion of CPR results in the inactivation of multiple P450s in the liver.
Intriguingly, mice lacking hepatic CPR exhibited a profound increase in cytochrome P450 content; in males the increase was 450%, while in females it was greater than 500% (Fig. 4b) . This large increase in P450 expression was further demonstrated by immunoblotting of hepatic microsomes with antisera to P450s from different gene families (Fig. 4c) . For certain of the enzymes, e.g. members of CYP2B and CYP3A gene families, the induction was at least as much as observed when potent exogenous P450 inducers are administered to mice. Hepatic immunostaining clearly
showed that while expression of CYP3A P450s was confined to the perivenous or centrilobular area in wild-type mice, as has been previously reported (19, 20) , in null mice CYP3A was localised throughout the section at high levels (Fig. 4d) .
Hepatic drug metabolism in CPR hepatic null mice
Acetaminophen was administered as a single intraperitoneal dose (300mg/kg body weight) to male wild-type and hepatic CPR null mice (Fig. 5a, b) . In wild-type mice, a 90% decrease in hepatic glutathione occurred within one hour of administration (Fig. 5a ), whereas the level remained unchanged in hepatic CPR nulls. Furthermore, 24h after treatment, wild-type mice showed a marked rise in serum ALT, indicative of extensive, potentially fatal, liver damage, whereas in mice lacking hepatic CPR ALT remained unchanged. 
Discussion
CPR is a multi-domain protein containing NADPH/ flavinadeninedinucleotide (FAD) and flavinmononucleotide (FMN) binding domains (7, 21) . When expressed in E. coli, these domains fold to form a functional polypeptide, which can, in the case of the FAD domain, independently catalyse the one electron reduction of a number of foreign compounds (7) . For this reason, the targeting construct was designed to ensure deletion of both of these domains (Fig. 1a) , and also utilised the Cre/loxP to allow the conditional deletion of CPR and circumvent the anticipated embryonic lethality of a complete CPR knockout (8) . The data presented in the current study is based on the generation of mice from targeted ES cells such that these mice retain all three loxP sites and the selectable The Cre ALB transgene has previously been shown to work with high efficiency in other systems, and in this study resulted in a reduction in hepatic CPR activity of more than 90% in both males and females (Fig. 2b ) by 6-8 weeks postpartum. The residual CPR activity observed in hepatic microsomal preparations from CPR hepatic null mice could be explained by the restriction of albumin promotor activity (and thus Cre recombinase expression) to hepatocytes (10) leaving CPR activity undiminished in other liver cell types. This would also account for the CPR immunostaining observed in individual cells in liver sections (Fig. 2c) . A further explanation could lie with an alternative electron donor to P450s, i.e. the cytochrome b5/NADH b5reductase system. CPR has recently been reported to be deleted in Saccharomyces cerevisiae and such altered yeast are apparently able to survive by using the cytochrome b5/NADH reductase system to supply both electrons to the P450 during the catalytic cycle (18) . However, although cytochrome b5 has been implicated as participating in the electron transfer cycle for P450s, often resulting in higher P450 activity (22) , cytochrome b5 has classically been deemed capable of undertaking transfer of the second, but not the first, electron in the P450 catalytic cycle, and this would seem to be confirmed by the embryonic lethality observed in homozygous CPR null mice (8) .
Intriguingly, hepatic CPR null mice were found to have an appreciably lower level of serum cholesterol, despite the profoundly raised lipid content of the liver (Fig. 3e) . These phenomena may be rationalised by the inability of these mice both to synthesise cholesterol de novo, (resulting in reduced circulating levels) and to degrade cholesterol through the bile acid biosynthetic pathway (to generate increased hepatic levels). This is consistent with the observation that hepatic CPR null mice have significantly reduced (~90%) bile acid production (Fig. 3d) . Both of these processes involve and CYP7A1 (cholesterol 7α-hydroxylase) (25) (26) (27) at the rate-limiting step of cholesterol metabolism in the classical or 'neutral' bile acid biosynthetic pathway. Under normal circumstances, cholesterol accumulation in the liver would trigger the feedback down-regulation of cholesterol uptake and biosynthesis by inhibiting the action of the SREBP transcription factors on a number of key lipogenic genes such as HMGCoA reductase, HMGCoA synthase and squalene synthase, and also the LDL receptor (28) . It is interesting to note that transgenic mice expressing a truncated 'dominant positive' form of SREBP1 also displays hepatomegaly with elevated lipid content of the liver (29) . However, these mice had essentially normal serum lipid chemistry, which was speculated to be due to an alteration in lipid metabolism such that lipids were stored in, rather than secreted from, the liver. Hayhurst et al. recently reported the conditional deletion of HNF4α in mouse liver (30) . This transcription factor, a member of the nuclear receptor superfamily, appears to play a key role in the maintenance of lipid homeostasis; mice lacking liver expression of HNF4α displayed a similar hepatic phenotype (increased liver/body weight, elevated hepatic lipids, reduced serum cholesterol) than described for hepatic CPR null mice in this study. Interestingly, we and others have shown that HNF4 plays an important role in the regulation of cytochrome P450s in the CYP2 gene family (31, 32) .
Although the liver is considered to be the major organ for cholesterol biosynthesis, almost all tissues possess the capacity to produce cholesterol (33) , reviewed in (34) . In the rat, for example, the liver is responsible for approximately half of all de novo cholesterol synthesis, with the major extrahepatic tissues involved being small intestine and skin; however, the contribution of different organs to cholesterol homeostasis can vary significantly between species (35). The other significant source of cholesterol is dietary, although cholesterol itself is not an essential nutrient, and intestinal absorption is relatively inefficient, varying considerably even within species, including mice and humans (36, 37) . A recent review of cholesterol and hepatic lipoprotein assembly proposed that the liver may be segregated into 'metabolic zones', with the periportal region undertaking the assembly of VLDL and being the major site of lipogenesis (anabolic phenotype), and the pericentral area exhibiting a catabolic phenotype, being the main location of LDL receptor and CYP7A1 expression and therefore undertaking the biosynthesis of bile acids from cholesterol (38) . These authors also suggested a link between these two processes, with the induction of bile acid synthesis (increased CYP7A1 expression) leading to increased transcription of genes regulated by SREBP. CYP7A1 null mice (26) exhibit a complex phenotype including increased mortality in the postnatal period, although those which survive to 3 weeks of age thereafter develop normally by utilising an alternative, 'acidic', bile acid biosynthetic pathway located in the mitochondrion, involving the sterol 27-hydroxylase (CYP27) (27) . The fact that the hepatic CPR null mice described in this study do not exhibit the same phenotype as the CYP7A1 null mice may be explained by the inactivation of hepatic P450s involved in the acidic pathway downstream from CYP27, i.e. CYP7B1 (39, 40) . The change in circulating triglycerides in the hepatic CPR null mice identifies a potentially novel function of hepatic P450 enzymes. Although P450s from the CYP4A gene family have been shown to metabolise lipids (41) this activity will be lost in hepatic CPR null mice and cannot explain the changes observed. Hepatic CPR null mice therefore constitute an ideal model with which to study this phenomenon.
The profound consequences for drug metabolism and toxic response in mice lacking hepatic CPR are illustrated both in vitro, with the almost complete ablation of testosterone hydroxylation (Fig. 4a) , and in vivo with acetaminophen and pentobarbital (Fig. 5) . The analgesic drug acetaminophen is activated by the P450 system to a highly reactive hepatotoxic intermediate, Nacetylbenzoquinonimine (NAPQI), a reaction undertaken mainly by CYP1A2 and CYP2E1 (42) (43) (44) .
Normally, NAPQI is subsequently detoxified by conjugation with glutathione, leading to a significant in hepatic levels of this thiol (45, 46) , and this was indeed observed in wild-type mice (Fig   5a) . In contrast, no such change was seen in hepatic CPR null mice, indicating that little or no NAPQI had been formed due to the lack of a functional hepatic microsomal P450 system.
The activity of the cytochrome P450 system can also be assessed by measuring the sleeping time of animals exposed to barbiturate drugs, the length of sleep reflecting the rate of P450-mediated metabolism (11) . In order to establish the role of hepatic P450s in the disposition of pentobarbital, wild-type and hepatic CPR null mice were administered an intraperitoneal dose of 20mg/kg body weight. Such a dose was non-narcotic to wild-type mice with normal levels of CPR (Fig. 5c); however, hepatic null mice, lacking a functional hepatic microsomal P450 system, slept for a period in excess of 2 hours. Mice which were heterozygous null for CPR slept for less than one hour, not only demonstrating a clear gene-dosage effect, but also that CPR activity is rate-limiting in vivo for the metabolism of this substrate.
Cytochrome P450s involved in drug metabolism are distributed throughout the tissues of the body; it has been estimated that a significant proportion of drug metabolism (up to 30%) may be extra-hepatic. The profound changes in drug response described above show that extra-hepatic metabolism plays only a minor role in the disposition of these compounds, at least in the mouse. The data also further demonstrate that the potential alternate electron transport pathway for P450s, from NADH via cytochrome b5/b5 reductase, plays only a minimal role, if any, in drug disposition.
One unexpected consequence of deleting hepatic CPR was the finding that the P450 content of the liver was increased by a factor of approximately five (Fig 4b) . This increase, which was found in both male and female mice, was evident in several different P450 sub-families (Fig. 4c) , with expression going from essentially undetectable in wild-type mice to significant levels for CYP2B
and CYP3A proteins in hepatic CPR nulls, and resulted in pan-lobular P450 expression rather than the zonal P450 expression usually found (Fig. 4d) (19, 20) . Cytochrome P450 isozymes provide an adaptive response to environmental challenge, and certain isozymes can be induced in the liver by a wide range of endogenous agents (47, 48) . In most cases, enzymes are induced in a specific manner according to the inducing agent, which results in an increased rate of disposition of the compound.
Apart from the role of hormones in the regulation of certain hepatic P450s (49,50) essentially nothing is known about the factors which regulate the endogenous levels of these enzymes. The profound induction of P450s in the hepatic CPR nulls, across a range of P450 subfamilies, is therefore intriguing and suggests that there may be a single key endogenous regulatory pathway which becomes activated (or inactivated) in the absence of P450 activity. Although it is feasible that in the absence of metabolism specific endogenous agents, such as glucocorticoids, may accumulate in the liver, such a phenomenon would not explain the generalised P450 induction seen in the hepatic CPR null mice. To our knowledge, the only similar pan-family induction of the P450 system observed in mice is that seen following administration of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) (51, 52) . Since this compound does not inhibit CPR activity, it will be intriguing to establish whether a common mechanism is involved.
The data presented in this study demonstrate unequivocally that we have specifically deleted hepatic CPR in the mouse. One of the most intriguing aspects of this model is that through the deletion of a single gene the functions of an entire multi-gene family (microsomal cytochrome P450s) have been ablated in a tissue-specific manner, resulting not only in a profound reduction in bile acid production but also in the metabolism of a hormone, testosterone, and drugs such as pentobarbital and acetaminophen. In spite of the hepatic phenotype, hepatic CPR null mice live and reproduce normally; indeed, we now have mice over 18 months of age. This unexpected finding means, at least in mice, that the hepatic P450 system in adults is not essential for life and furthermore accentuates its fundamental role in providing protection from toxic environmental agents. Currently, the hepatic metabolism of endogenous molecules such as steroid hormones does not appear to be of major significance in endogenous hormone homeostasis. However, the P450 system does appear to play a major role in regulating lipid homeostasis and hepatic lipid levels. 
